IC
MGRX icon

Ikarian Capital’s Mangoceuticals MGRX Stock Holding History

Ikarian Capital’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5K Hold
138,146
– – 0.01% 150
2026
Q1 		$49.7K Hold
138,146
– – ﹤0.01% 154
2025
Q4 		$102K Buy
+138,146
New +$224K 0.01% 163

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Ikarian Capital's MGRX Position: Q2 2026 in Review

Ikarian Capital held its Mangoceuticals (MGRX) position steady in Q2 2026 at 138,146 shares worth $52.5K. The position accounts for 0.01% of the portfolio, ranked #150.

Ikarian Capital first reported a position in MGRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $102K in Q4 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Ikarian Capital held 138,146 shares of Mangoceuticals worth $52.5K as of Q2 2026.
  • Ikarian Capital left its Mangoceuticals share count unchanged in Q2 2026.
  • Mangoceuticals made up 0.01% of Ikarian Capital's portfolio in Q2 2026, its #150 holding.
  • Ikarian Capital first reported a position in Mangoceuticals in Q4 2025 and has held it in 3 quarters since.
  • Ikarian Capital's Mangoceuticals position peaked at $102K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.